Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Operating Margin | Operating Income | Revenues |
---|---|---|---|
6/30/2025 | -160.2% | $ -7.92M | $ 4.94M |
3/31/2025 | -164.29% | $ -8.08M | $ 4.92M |
12/31/2024 | -160.71% | $ -7.77M | $ 4.83M |
9/30/2024 | -146.44% | $ -7.26M | $ 4.96M |
6/30/2024 | -176.92% | $ -8.13M | $ 4.6M |
3/31/2024 | -118.06% | $ -6.64M | $ 5.63M |
12/31/2023 | -127.48% | $ -6.99M | $ 5.49M |
9/30/2023 | -159.52% | $ -7.52M | $ 4.72M |
6/30/2023 | -202.6% | $ -8.38M | $ 4.14M |
3/31/2023 | -614.83% | $ -14.38M | $ 2.34M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Op. Inc. / Revenues
(=) Operating %
Operating % for INMED PHARMACEUTICALS INC is calculated as follows: Op. Inc. [ $ -9.94M ] / Revenues [ $ 0 ]
(=) Operating % [ 0% ]
Minimum
Dec 31, 2021
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.26K |
---|---|
min | -71.54% |
max | 83.41% |
average | 9.03% |
median | 8.77% |
std | 23.72% |